Hu-antibody-positive patients with or without cancer have similar clinical profiles.
Lladó
A
A
Carpentier
A F
AF
Honnorat
J
J
Sillevis-Smitt
P
P
Twijnstra
A
A
Blanco
Y
Y
Hart
I K
IK
Saiz
A
A
Graus
F
F
D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D000917:Antibody Formation; D016022:Case-Control Studies; D051959:ELAV Proteins / Q000276:immunology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000276:immunology*; D020364:Paraneoplastic Polyneuropathy / Q000276:immunology*
D000974:Antibodies, Antinuclear; D051959:ELAV Proteins